These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14691127)

  • 1. Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?
    Appelbaum FR
    J Clin Oncol; 2004 Feb; 22(3):390-1. PubMed ID: 14691127
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloid growth factors should not be administered routinely after allogeneic hematopoietic stem-cell transplantation.
    Mehta J
    J Clin Oncol; 2004 Nov; 22(21):4429-30; author reply 4430-2. PubMed ID: 15514388
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiapoptotic effect of growth factors in leukemia.
    Liu WM; Baird R; Sarker D; Powles T
    J Clin Oncol; 2005 Jan; 23(3):649; author reply 649-50. PubMed ID: 15659515
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia.
    Welte K; Riehm H
    N Engl J Med; 1997 Oct; 337(18):1320; author reply 1321. PubMed ID: 9380088
    [No Abstract]   [Full Text] [Related]  

  • 9. [Improvement of thrombocytopenia by administration of M-CSF in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Endo A; Tajima F; Kawatani T; Kawasaki H
    Rinsho Ketsueki; 1996 Sep; 37(9):863-6. PubMed ID: 8914477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous bone marrow transplantation in malignant hematologic tumors--the current status and future problems involving children].
    Takayama J; Ohira M
    Rinsho Ketsueki; 1992 Jul; 33(7):929-33. PubMed ID: 1507414
    [No Abstract]   [Full Text] [Related]  

  • 11. Acalculous cholecystitis after bone marrow transplantation in adults with acute leukaemia. Case report.
    Pitkäranta P; Haapiainen R; Taavitsainen M; Elonen E
    Eur J Surg; 1991 May; 157(5):361-4. PubMed ID: 1678652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation in acute lymphoblastic leukemia (ALL).
    Santos GW
    Leukemia; 1992; 6 Suppl 2():198. PubMed ID: 1578933
    [No Abstract]   [Full Text] [Related]  

  • 14. Current progress in the treatment of adult acute leukemia in Japan.
    Ohno R
    Jpn J Clin Oncol; 1993 Apr; 23(2):85-97. PubMed ID: 7685836
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
    Devine SM; Brown RA; Mathews V; Trinkaus K; Khoury H; Adkins D; Vij R; Sempek D; Graubert T; Tomasson M; Goodnough LT; DiPersio JF
    Bone Marrow Transplant; 2005 Sep; 36(6):531-8. PubMed ID: 16025152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of HGF on graft-versus-host disease and graft-versus-leukemia after allogeneic bone marrow transplantation in acute lymphoblastic leukemia mice].
    Xia YJ; Gao QP; Wan CC; Cheng FJ; Liu ZX; Guo RC
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):404-7. PubMed ID: 16251021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia.
    Huang XJ; Chen YH; Xu LP; Zhang YC; Liu DH; Guo NL; Lu DP
    Chin Med J (Engl); 2004 Apr; 117(4):604-7. PubMed ID: 15109458
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
    Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
    Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged thrombocytopenia after administration of granulocyte colony-stimulating factor and leukapheresis in a donor for allogeneic peripheral blood stem cell transplantation.
    Okamoto S; Ishida A; Wakui M; Tanosaki R; Oda A; Ikeda Y
    Bone Marrow Transplant; 1996 Aug; 18(2):482-3. PubMed ID: 8864472
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.